Search

Your search keyword '"Kravchun N"' showing total 129 results

Search Constraints

Start Over You searched for: Author "Kravchun N" Remove constraint Author: "Kravchun N"
129 results on '"Kravchun N"'

Search Results

1. Impact of hypoglycemia on daily life of type 2 diabetes patients in Ukraine

2. Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial

3. Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis

4. Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease: Results from the CREDENCE trial and meta-analysis

7. Прогнозування ризику розвитку остеопорозу в пацієнтів із цукровим діабетом 2 типу та неалкогольною жировою хворобою печінки

9. FUNCTIONAL RELEVANCE OF THE INTERLEUKINE-6 GENE POLYMORPHISM RS1800795 IN PATIENTS WITH T YPE 2 DIABETES OF THE EAST UKRAINIAN POPULATION

12. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

14. Неінвазивні маркери фіброзу та еластографія в діагностиці тяжкості фіброзу у хворих на цукровий діабет 2 типу та неалкогольну жирову хворобу печінки

15. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

16. Osteoporosis risk prediction in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease

17. Non-invasive fibrosis markers and elastography in diagnosis of fibrosis severity in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease

23. The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics

24. This title is unavailable for guests, please login to see more information.

25. This title is unavailable for guests, please login to see more information.

26. This title is unavailable for guests, please login to see more information.

27. This title is unavailable for guests, please login to see more information.

28. Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups Results From the Randomized CREDENCE Trial

29. HEPATIC FIBROSIS AS AN ADDITIONAL RISK FACTOR FOR THE DEVELOPMENT OF CARDIOVASCULAR DISORDERS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH NON-ALCOHOLIC FATTY LIVER DISEASE.

30. Circulating levels of tumor necrosis factor-alpha in type 2 diabetes mellitus patients with non-alcoholic fatty liver disease taking into account the vascular complications

41. METABOLIC DISBALANCE IN TYPE 2 DIABETES MELLITUS PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE TAKING INTO ACCOUNT THE SINGLE NUCLEOTIDE POLYMORPHISM – 308 G/A OF TUMOR NECROSIS FACTOR-ALPHA (TNF) GENE

44. Adiponectin gene single-nucleotide polymorphisms in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease

45. RELATIONSHIP WITH EXPRESSIVENESS OF ALEXITHYMIA WITH PARAMETERS OF CARBOHYDRATE METABOLISM IN PATIENTS WITH TYPE 2 DIABETES IN NONALCOHOLIC FATTY LIVER DISEASE AND OBESITY (Literature review and own data)

Catalog

Books, media, physical & digital resources